| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |